Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Glucagon-like peptide 2 (GLP-2) is a newly discovered intestinotrophic hormone. We have recently reported that a 5-week GLP-2 treatment improved the intestinal absorptive capacity of short-bowel patients with no colon. Additionally, GLP-2 treatment was associated with changes in body composition that included a significant increase in total body bone mass. This article describes the effect of GLP-2 on spinal and hip bone mineral density (BMD) and biochemical markers of bone turnover in these patients.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Scandinavian Journal of Gastroenterology |
Vol/bind | 37 |
Udgave nummer | 4 |
Sider (fra-til) | 392-8 |
Antal sider | 7 |
ISSN | 0036-5521 |
Status | Udgivet - 1 apr. 2002 |
ID: 33793088